LDS/Medical Tests/Enhancer of zeste homolog 2 (EZH2) Gene Mutation Analysis

Enhancer of zeste homolog 2 (EZH2) Gene Mutation Analysis

The EZH2 (Enhancer of zeste homolog 2) gene, located at 7q36.1 chromosome encodes for histone methyltransferase which is involved in chromatin modeling and transcriptional repression. EZH2 along with EED (Embryonic Ectoderm Development protein, mouse, homolog of) and SUZ12 (Suppressor of Zeste 12, drosophila, homolog of) is the catalytic subunit of Polycomb repressive complex-2 (PRC2). PRC2 catalyzes the methylation of histone H3 at lysine 27 (H3K27) to generate trimethylated H3K27. This methylated H3K27 results in chromatin compaction and initiates epigenetic silencing of genes involved in cell fate decisions.

Aberrant expression of the protein due to mutations of EZH2 have been associated with Weaver Syndrome. EZH2 mutations have also been identified, although not confirmatory, in various solid tumors and hematological malignancies. A monoallelic activating Tyr646 mutation is associated with lymphomas while mono and biallelic missense and truncating mutations are linked to poor prognosis in myelodysplastic and myeloproliferative neoplasms. Interactions of EZH2 with estrogen receptor (ER) α and β catenin has shown to regulate c-Myc and cyclin D expression in breast cancer cells.

Weaver syndrome is a rare congenital disease first reported in 1974. It is characterized by tall stature, generalized overgrowth, macrocephaly, advanced bone age and facial deformities. It is occasionally accompanied with intellectual disability and increased susceptibility to cancer. Other EZH2 associated clinical features include poor coordination, hypotonia or hypertonia, soft skin, campodactyly and umbilical hernia.

  • As an aid in diagnosis of Weaver Syndrome
  • Carrier screening for relatives and those with the family history
  • Prenatal carrier screening for those with the family history
Mutation detected in the EZH2 gene might indicate disease. Sequencing analysis can identify small insertions and deletions, missense, non-sense and splice variants of EZH2 gene. The analytical sensitivity of this test is the detection of >99% single nucleotide changes and insertions and deletions <20 base pairs.

Negative for mutations analyzed (No pathogenic variant or mutation detected)

Sanger sequencing, Next generation sequencing.

Whole blood (EDTA), saliva, buccal swab.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
Macrocephaly Panel, NSD1 gene anaylsis for Sotos syndrome, NFIX gene analysis for Malan Syndrome.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login